These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25983774)

  • 1. Experimental treatments for mitochondrial dysfunction in sepsis: A narrative review.
    Zheng G; Lyu J; Huang J; Xiang D; Xie M; Zeng Q
    J Res Med Sci; 2015 Feb; 20(2):185-95. PubMed ID: 25983774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome.
    Dare AJ; Phillips AR; Hickey AJ; Mittal A; Loveday B; Thompson N; Windsor JA
    Free Radic Biol Med; 2009 Dec; 47(11):1517-25. PubMed ID: 19715753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 4. Sepsis, mitochondrial failure and multiple organ dysfunction.
    Duran-Bedolla J; Montes de Oca-Sandoval MA; Saldaña-Navor V; Villalobos-Silva JA; Rodriguez MC; Rivas-Arancibia S
    Clin Invest Med; 2014 Apr; 37(2):E58-69. PubMed ID: 24690420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial function in sepsis.
    Jeger V; Djafarzadeh S; Jakob SM; Takala J
    Eur J Clin Invest; 2013 May; 43(5):532-42. PubMed ID: 23496374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energetic dysfunction in sepsis: a narrative review.
    Preau S; Vodovar D; Jung B; Lancel S; Zafrani L; Flatres A; Oualha M; Voiriot G; Jouan Y; Joffre J; Uhel F; De Prost N; Silva S; Azabou E; Radermacher P
    Ann Intensive Care; 2021 Jul; 11(1):104. PubMed ID: 34216304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality.
    Larche J; Lancel S; Hassoun SM; Favory R; Decoster B; Marchetti P; Chopin C; Neviere R
    J Am Coll Cardiol; 2006 Jul; 48(2):377-85. PubMed ID: 16843190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Mechanisms in Septic Cardiomyopathy.
    Cimolai MC; Alvarez S; Bode C; Bugger H
    Int J Mol Sci; 2015 Aug; 16(8):17763-78. PubMed ID: 26247933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach.
    Mokhtari B; Yavari R; Badalzadeh R; Mahmoodpoor A
    Can J Infect Dis Med Microbiol; 2022; 2022():3277274. PubMed ID: 35706715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy.
    Pan P; Wang X; Liu D
    J Int Med Res; 2018 Jun; 46(6):2157-2169. PubMed ID: 29637807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of mitochondrial function in sepsis and critical illness.
    Harrois A; Huet O; Duranteau J
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):143-9. PubMed ID: 19390243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Decision-Support Systems for Detection of Systemic Inflammatory Response Syndrome, Sepsis, and Septic Shock in Critically Ill Patients: A Systematic Review.
    Wulff A; Montag S; Marschollek M; Jack T
    Methods Inf Med; 2019 Dec; 58(S 02):e43-e57. PubMed ID: 31499571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model.
    Zapelini PH; Rezin GT; Cardoso MR; Ritter C; Klamt F; Moreira JC; Streck EL; Dal-Pizzol F
    Mitochondrion; 2008 Jun; 8(3):211-8. PubMed ID: 18417427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of mitochondrial respiration in relation to sepsis-induced multiple organ dysfunction.
    Kohoutová M; Dejmek J; Tůma Z; Kuncová J
    Physiol Res; 2018 Dec; 67(Suppl 4):S577-S592. PubMed ID: 30607965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and antioxidant therapy in sepsis.
    Rocha M; Herance R; Rovira S; Hernández-Mijares A; Victor VM
    Infect Disord Drug Targets; 2012 Apr; 12(2):161-78. PubMed ID: 22420514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock.
    Protti A; Fortunato F; Artoni A; Lecchi A; Motta G; Mistraletti G; Novembrino C; Comi GP; Gattinoni L
    Crit Care; 2015 Feb; 19(1):39. PubMed ID: 25757508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants.
    Víctor VM; Espulgues JV; Hernández-Mijares A; Rocha M
    Infect Disord Drug Targets; 2009 Aug; 9(4):376-89. PubMed ID: 19689380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome.
    Crouser ED
    Mitochondrion; 2004 Sep; 4(5-6):729-41. PubMed ID: 16120428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review.
    Önal U; Valenzuela-Sánchez F; Vandana KE; Rello J
    Healthcare (Basel); 2018 Sep; 6(3):. PubMed ID: 30177659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Dysregulation in Sepsis: A Literature Review.
    Graham JK; Stacy K
    Clin Nurse Spec; 2020; 34(4):170-177. PubMed ID: 32541603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.